首页 | 本学科首页   官方微博 | 高级检索  
     

辛伐他汀对血脂正常的急性冠脉综合征患者炎症因子及预后的影响
引用本文:卢杰. 辛伐他汀对血脂正常的急性冠脉综合征患者炎症因子及预后的影响[J]. 西南科技大学学报(哲学社会科学版), 2009, 7(2): 99-100
作者姓名:卢杰
作者单位:沈阳医学院沈洲医院,110002  
摘    要:目的观察血脂正常的急性冠脉综合征(ACS)早期应用辛伐他汀对C反应蛋白(CRP)及心血管事件发生的影响。方法将64例血脂正常的急性冠脉综合征患者随机分为治疗组(n=32除常规治疗外加服辛伐他汀20mg)和对照组(n=32仅常规治疗),于治疗前、治疗4w后观察C反应蛋白变化,心血管事件发生次数。结果治疗组于治疗后CRP有明显下降(1.76mg/L对2.11mg/L,P〈0.05),并明显低于对照组(1.76mg/L对2.08mg/L,P〈0.05),心血管事件也明显少于对照组(9.4%对31.3%,P〈0.05)。结论辛伐他汀对血脂正常的ACS早期治疗能明显降低CRP水平,抑制炎症反应,稳定易损斑块,减少心血管事件的发生。

关 键 词:辛伐他汀  血脂  急性冠脉综合征C反应蛋白  心血管事件

The effects of simvastatin on inflammation facrors in patients with mean serum lipid in acute coronary artery syndrome(ACS)
LV Jie. The effects of simvastatin on inflammation facrors in patients with mean serum lipid in acute coronary artery syndrome(ACS)[J]. Journal of Southwest University of Science and Technology, 2009, 7(2): 99-100
Authors:LV Jie
Affiliation:LV Jie.Shenzhou Hospital of Shenyang Medical College,Shenyang 110002,China.
Abstract:Objective To evaluate the effection of Simvastatin on C-reactive protein(CRP) and the cardiovascular attacts in the patients with ACS,however,without dyslipidemia.Method A cohort of 64 patients with ACS but mean serum lipid was randomly assigned to Simvastatin group(n=32 Simvastatin 20mg based on routine treatment) and control group(n=32 only received routine treatment).Recorded the change of CRP and number of cadouvascular attacts before and 4 weeks after treatment.Results CRP in Simvastatin group signific...
Keywords:Simvastatin  Serum lipid  Acute Coronary Artery Syndrome  C-reactive protein  Cadiovascular attacts  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号